The test measures several factors, including anti-müllerian hormone (AMH), testosterone, and thyroid levels, to determine potential hormonal imbalances and conditions, including polycystic ovarian syndrome. Additionally, the test analyzes metabolic factors, including insulin resistance, cholesterol levels, vitamin deficiencies, and inflammation levels.
November 2, 2021
A research team led by Dr. Shant Ayanian, an assistant professor of medicine at the GW School of Medicine & Health Sciences, evaluated 299 patients diagnosed with COVID-19 and admitted to GW Hospital between March 12 and May 9 (Future Medicine, July 17, 2020). More than two-thirds (200) of the patients had all five biomarkers evaluated: interleukin-6 (IL-6), D-dimer, C-reactive protein (CRP), lactate dehydrogenase (LDH), and ferritin. Elevated levels of the biomarkers were associated with inflammation and bleeding disorder, showing an independent increased risk for intensive care unit admission, invasive ventilatory support, and death.
August 6, 2020